Product Images Doxorubicin Hydrochloride

This is a product information sheet for the use and dosage of Doxorubicin Hydrochloride Liposome Injection, an intravenous infusion for which the instructions specify the use of 5% Dextrose Injection, USP. The instructions include details on the contents of the injection and its liposomal formulation. The document also includes instructions for storage and proper disposal of the unused medicine. The information sheet is intended for use by healthcare professionals and provides a phone number to contact the manufacturer with questions.*

This is a pharmaceutical product label for Doxorubicin Hydrochloride Liposome Injection, which is a cytotoxic agent for intravenous infusion, stating that it must be diluted prior to use and the liposomal formulation should not be substituted. It also provides the manufacturer details and drug's composition. The recommended dosage is not mentioned, advising to see the prescription information. The text also includes some identification numbers, a warning to discard unused portions, and a notice to store the product at a temperature range between 2°C and 8°C but avoid freezing. The text is not-readable in parts, likely because of errors.*

This is a representation of a liposome which has been coated with MPEG-DSPE and contains an aqueous core with entrapped doxorubicin HCI. The liposome is made up of a bilayer.*

This is a clinical trial description comparing the efficacy of two treatments, Doxorubicin+Bortezomib and Bortezomib, for a certain medical condition. The analysis of the data indicates a statistically significant difference between the treatments, with a p-value < 0.0001 and a hazard ratio of 0.55. The data is presented in a table showing the number of subjects at risk over time. The text also includes some formatting elements such as numbers and symbols.*

Use 5% Dextrose Injection, USP to dilute Doxorubicin Hydrochloride liposome injection. The usual dosage can be found in the prescribing information. The vial should be kept in its carton until use. This is a cytotoxic agent that must be diluted and is only for intravenous infusion. The liposomal formulation should not be substituted. This must be stored refrigerated and should not be frozen. The 10 mL vial is manufactured by Sun Pharmaceutical Industries Ltd. for BluePoint Laboratories. A lot number and expiration date are provided.*

This text provides instructions and important details about Doxorubicin Hydrochloride Liposome Injection, a cytotoxic agent that must be diluted before intravenous infusion. It emphasizes using 5% Dextrose Injection, USP for dilution, and cautions not to substitute for other formulations. The usual dosage is not provided, and the user is directed to see the prescribing information. The vial must be stored in a refrigerator and should not be frozen. The text also indicates the manufacturer and information about the lot and expiration date.*

The provided text is a structural formula for an unknown compound with the abbreviation HSPC. The formula shows a chain of atoms consisting of carbon, nitrogen, oxygen, and hydrogen atoms. The abbreviation "mn" is given with a value of either 14 or 16, which may refer to the molar mass or atomic mass of the compound.*